Effects of hypertension and ovariectomy on rat hepatocytes. Are amlodipine and lacidipine protective? (A stereological and histological study)

Turkish Journal of Gastroenterology

Volumn 21, Issue 4, 2010, Pages 387-395

  Dursun, Hakan ^a   Albayrak, Fatih ^a   Uyanik, Abdullah ^a   Keleş, Nuri Osman ^a   Beyzagül, Polat ^a   Bayram, Ednan ^b   Halici, Zekai ^a   Altunkaynak, Zuhal Berrin ^a   Süleyman, Halis ^a   Okçu, Nihat ^a   Ünal, Bünyamin ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b Department of Cardiology   (Turkey)

Author keywords

Amlodipine; Hypertension; Lacidipine; Liver; Ovariectomy; Stereology

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; LACIDIPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL VACUOLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HYPERTENSION; LIVER CELL; LIVER PROTECTION; LIVER SINUSOID; MONONUCLEAR CELL; NONHUMAN; OUTCOME ASSESSMENT; OVARIECTOMY; PORTAL VEIN; POSTMENOPAUSE; RAT;

AMLODIPINE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CYTOPROTECTION; DIHYDROPYRIDINES; FEMALE; HEPATOCYTES; HYPERTENSION; LIVER; OVARIECTOMY; POSTMENOPAUSE; RATS; RATS, INBRED STRAINS;

EID: 79951993437     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2010.0125     Document Type: Article

References (40)

1. Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Medicine 1999; 19: 1447-57. (Pubitemid 29513462)
2. Opie LH. Pharmacological difference between calcium antagonists. Eur Heart J 1999; 18: 71-9.
3. Michel T. Godman and Gilman's The Pharmacological Basis of Therapeutics. In: Brunton L, ed. New-York: McGraw-Hill, 2006; 832-8.
4. Yaǧmurdur MC, Ozdemir A, Topaloǧlu S, et al. Effects of alpha tocopherol and verapamil on liver and small bowel following mesenteric ischemia-reperfusion. Turk J Gastroenterol 2002; 13: 40-6. (Pubitemid 34273141)
5. Galisteo M, García-Saura MF, Jimenez R, et al. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats. Mol Cell Biochem 2004; 2: 91-9. (Pubitemid 38519220)
6. McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension: the role of superoxide anion. Hypertension 1999; 34: 539-45. (Pubitemid 29496430)
7. Halici Z, Borekci B, Ozdemir Y, et al. Protective effects of amlodipine and lacidipine on ovariectomy-induced bone loss in rats. Eur J Pharmacol 2008; 579: 241-5.
8. Suleyman H, Halici Z, Hacimuftuoglu A, Gocer F. Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers. Pharmacol Rep 2006; 58: 692-9. (Pubitemid 44741688)
9. Halici Z, Suleyman H, Cadirci E. Effects of calcium channel blockers on hyaluronidase-induced capillary vascular permeability. Arch Pharm Res 2008; 31: 891-9.
10. Kataoka C, Egashira K, Ishibashi M, et al. Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. Am J Physiol Heart Circ Physiol 2004; 286: 768-74.
11. Haller H, Cosentino F, Luscher TF. Endothelial dysfunction, hypertension and atherosclerosis. A review of the effects of lacidipine. Drugs R D 2002; 3: 311-23.
12. Jukema JW, Van Der Hoorn JW. Amlodipine and atorvastatin in atherosclerosis. Expert Opin Pharmacother 2004; 5: 459-68.
13. Garzotti M. Lacidipine, a potential peroxynitrite scavenger: investigation of activity by liquid chromatography and mass spectrometry. Rapid Commun Mass Spectrom 2003; 17: 272-8. (Pubitemid 36193665)
14. Wang WZ, Matsumori A, Yamada T, et al. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production. Circulation 1997; 95: 245-51.
15. Szabó C, Thiemermann C, Vane JR. Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem Biophys Res Commun 1993; 196: 825-30. (Pubitemid 23337681)
16. Sayama H, Nakamura Y, Saito N, Konoshita M. Does the plasma endothelin-1 concentration reflect atherosclerosis in the elderly? Gerontology 1999; 45: 312-6.
17. Kunz J. Initial lesions of vascular aging disease (arteriosclerosis). Gerontology 2000; 46: 295-9.
18. Chobanian AV, Bakris GL, Black HR, et al. and for the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, and National High Blood Pressure Education Program Coordinating Committee, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52. (Pubitemid 37553153)
19. Bezerra DG, Pires KM, Mandarim de-Lacerda CA. Amlodipine preserves the glomerular number in spontaneously hypertensive rats. J Cell Mol Med 2005; 9: 966-71. (Pubitemid 43116560)
20. Halici Z, Bilen H, Albayrak F, et al. Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes? Eur J Pharmacol 2009; 614: 146-52.
21. Kaplan S, Canan S, Aslan H, Unal B, Sahin B. A simple technique to measure the movements of the microscope stage along the x and y axes for stereological methods. J Microsc 2001; 203: 321-5. (Pubitemid 33755971)
22. Howard CV, Reed MG. Unbiased Stereology: Three Dimensional Measurement in Microscopy. Oxford: Bios Scientific Publishers, 1998; 1-37.
23. Sader MA, Celermajer DS. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res 2002; 53: 597-604. (Pubitemid 34175252)
24. Dubey RK, Jackson EK. Genome and hormones: gender differences in physiology review: cardiovascular protective effects of 17B-estradiol metabolites. J Appl Physiol 2001; 91: 1868-83.
25. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 2002; 53: 672-7.
26. Kisley LR, Sakai RR, Fluharty SJ. Estrogen decreases hypothalamic angiotensin II AT1 receptor binding and mRNA in the female rat. Brain Res 1999; 844: 34-42. (Pubitemid 29490950)
27. Nickenig G, Strehlow K, Wassmann S, et al. Differential effects of estrogen and progesterone and AT1 receptor gene expression in vascular smooth muscle cells. Circulation 2000; 102: 1828-33.
28. Nickenig G, Baumer AT, Grohe C, et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 1998; 97: 2197-201. (Pubitemid 28265380)
29. Harrison DG, Galis Z, Parthasarathy S, Griendling KK. Oxidative stress and hypertension. In: Izzo JL, Black HR, eds. Hypertension primer. Philadelphia, PA: Lippincott Williams & Wilkins, 1999; 163-6.
30. Shibuya M. Role of vegf-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995; 67: 281-316.
31. Williams B, Baker AG, Gallacher B, Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 1995; 25: 913-7.
32. Krishna P, Nakata M, Nakajima T, et al. Increased production of vascular endothelial growth factor (vegf) by angiotensin II. Neurosci Res Commun 1999; 25: 79-88. (Pubitemid 29521501)
33. Rosmorduc O, Wendum D, Corpechot C, et al. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 1999; 155: 1065-73. (Pubitemid 29488914)
34. Matsusaka T, Ichikawa I. Biological functions of angiotensin and its receptor. Annu Rev Physiol 1997; 59: 395-412. (Pubitemid 27142448)
35. Bataller R, Gines P, Nicolas JM, et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000; 118: 1149-56. (Pubitemid 30346992)
36. William JW. Angiotensin II-dependent superoxide effects on hypertension and vascular dysfunction. Hypertension 2008; 52: 51-6.
37. Halici Z, Karaca M, Keles ON, et al. Protective effects of amlodipine on ischemia-reperfusion injury of rat ovary: biochemical and histopathologic evaluation. Fertil Steril 2008; 90: 2408-15.
38. Bauer JH, Reams GP. Renal protection with calcium antagonism in essential hypertension. Clin Invest Med 1989; 12: 300-28.
39. Berkels R, Taubert D, Bartels H, et al. Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology 2004; 70: 39-45. (Pubitemid 37499989)
40. Chou TC, Yang SP, Pei D. Amlodipine inhibits proinflammatory cytokines and free radical production and inducible nitric oxide synthase expression in lipopolysaccharide/interferon-γ-stimulated cultured vascular smooth muscle cells. Jpn J Pharmacol 2002; 89: 157-63. (Pubitemid 34752301)